susan mcgowan tirzepatide Nurse's death linked to weight-loss drug Mounjaro approved on NHS Tragic Scots nurse had just

The pill offers a needle-free option while providing similar results

The cardiovascular benefits observed relate to major adverse cardiovascular events (MACE) rather than venous thrombotic disease

Health professionals are encouraged to watch for skin symptoms in people taking this medicine and to report these cases when they occur

PMID: 38 WheelerMBGellingRWMcIntoshCHGeorgiouJBrownJCPedersonRA

It's not just about losing weight, though many find that a benefit, but about feeling truly vibrant and in control of my health

Data for the weekly subcutaneous injection, revealed in June 2024, showed that petrelintide could elicit an average weight reduction of 8.6% at 16 weeks, compared with 1.7% in placebo counterparts